Yissum Research Development

Yissum Research Development, the technology transfer company of the Hebrew University of Jerusalem, focuses on transforming groundbreaking academic research into commercial opportunities across a variety of sectors including AgTech, Medical Devices, and Pharmaceuticals. Founded in 1964, Yissum Research Development is based in Jerusalem, Israel and operates as the technology transfer office for the Hebrew University of Jerusalem. The company specializes in developing and commercializing innovative technologies arising from academic research to solve real-world challenges. The firm is led by CEO Itzik Goldwaser, who has extensive experience in technology commercialization.

Yissum's global reach includes partnerships across North America, Europe, and Asia, aiding in the integration of its technologies into operational systems. Yissum excels in creating commercial opportunities from academic research, with a strong portfolio that includes AgTech, Chemistry and Nanotechnology, Computer Science and Engineering, Diagnostics, FoodTech and Nutrition, Medical Devices and Digital Health, Micro and OptoElectronics, Pharmaceuticals, Quantum Technologies, Social Sciences, Sustainability and Environment, and VetTech. Their offerings are aimed at addressing significant global challenges through advanced medical devices and innovative agricultural solutions, serving both industry partners and research institutions. Yissum generates revenue through strategic partnerships and collaborations with both private and public entities by licensing its patented technologies.

Revenue streams comprise upfront licensing fees along with ongoing royalties based on the sales of products developed with Yissum's technologies, particularly in the pharmaceutical and medical device sectors. This income structure allows Yissum to support ongoing research and development while facilitating the commercialization of academic innovations. Yissum is strategically focused on expanding its portfolio of technologies, particularly by developing new products in the fields of Medical Devices and Pharmaceuticals. The company aims to enhance its market presence in North America, Europe, and Asia by 2025.

Recent funding will be utilized to further accelerate product development and market penetration efforts, reinforcing Yissum's commitment to translating academic research into practical applications.